SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-211959
Filing Date
2021-07-09
Accepted
2021-07-09 17:05:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d194049dsc13da.htm SC 13D/A 34544
2 EX-99.C d194049dex99c.htm EX-99.C 26335
  Complete submission text file 0001193125-21-211959.txt   62442
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Subject) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91809 | Film No.: 211083453
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
BC Perception Holdings, LP (Filed by) CIK: 0001829166 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A